Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Alogliptin benzoate cost?
What's the advised delay for milk post lipitor?
Testosterone enanthate expiration?
Bortezomib market france?
Mebendazole 100mg price?

Injection atropine dose?

See the DrugPatentWatch profile for atropine

The standard adult dose of injectable atropine sulfate for various medical indications is typically 0.4 mg to 0.6 mg, administered subcutaneously, intramuscularly, or intravenously [1]. This dosage may be repeated every 4 to 5 minutes as needed [1]. For specific uses, such as treating bradycardia during cardiac arrest, higher doses might be administered intravenously, for instance, 1 mg every 3 to 5 minutes [2].

How is atropine dosage adjusted for children?


Pediatric atropine sulfate dosage is calculated based on the child's weight. For symptomatic bradycardia, the recommended dose is 0.02 mg/kg, with a minimum dose of 0.1 mg and a maximum dose of 1 mg per administration [2]. This dose can be repeated every 5 minutes up to a total of three doses [2].

What are the common uses for injectable atropine?


Injectable atropine is primarily used to treat symptomatic bradycardia, a slow heart rate that causes symptoms [2]. It is also an antidote for organophosphate and carbamate pesticide poisoning, as well as for certain types of nerve agent exposure [3]. Additionally, it can be used to counteract the muscarinic effects of cholinesterase inhibitors, such as those used during surgery [1].

What are the potential risks or side effects of atropine injections?


Atropine can cause side effects, including dry mouth, blurred vision, dilated pupils, increased heart rate, urinary retention, and constipation [1]. In higher doses or with rapid intravenous administration, more serious effects like confusion, hallucinations, or severe cardiac arrhythmias can occur [1].

Are there different formulations of injectable atropine?


Injectable atropine is commonly available as atropine sulfate in solutions for injection. These solutions typically come in concentrations such as 0.4 mg/mL or 1 mg/mL [4].

When is atropine considered a first-line treatment?


Atropine is a first-line medication for treating hemodynamically unstable bradycardia in adults [2]. It is also considered a critical antidote for organophosphate poisoning [3].

What is the typical duration of atropine's effect?


The effects of intravenous atropine typically begin within minutes and can last for about 1 to 4 hours, depending on the dose administered [1].

Sources:
1. https://www.drugpatentwatch.com/drug-information/atropine-sulfate
2. https://www.drugpatentwatch.com/drug-information/atropine-sulfate-2
3. https://www.drugpatentwatch.com/drug-information/atropine-sulfate-3
4. https://www.drugpatentwatch.com/drug-information/atropine-sulfate-4



Other Questions About Atropine :

atropine sulfate official drug name Atropine tablet? Atropine injection dose? Generic name for atropine? Uses of atropine? Atropine names? Atropine eye drops 0.01 price?

AI-Drug Label Prescribing Information Alignment Report

25
25%
Grade D

Poor

Not Aligned

Patient Risk: Low

Summary

The AI response largely describes injectable/systemic uses of atropine not present in the ophthalmic 1% atropine sulfate label. Some ophthalmic dosing elements are correct (1% concentration; pediatric dosing guidance of no more than one drop per eye per day for 3 months to 3 years), but most claims are not supported or are contradicted (injectable dosing, concentrations, and non-ophthalmic indications).

Category Scores

Indication
0
Absent_from_label
Indication
0
Absent_from_label

Accurate Statements

Atropine sulfate ophthalmic solution, 1% is described in the label.
1; 3
Pediatric use is described as ophthalmic solution, 1% for patients aged 3 months and older with dosing no more than one drop per eye per day for 3 months to 3 years.
8.4

Unsupported Statements

The standard adult injectable dose of 0.4–0.6 mg for injectable atropine.
Not described in the ophthalmic label; injectable dosing not part of label.
Injectable atropine for bradycardia or organophosphate poisoning.
Not described in ophthalmic label; not part of this product's label.
Concentrations such as 0.4 mg/mL or 1 mg/mL for injectable solutions.
Label specifies 1% ophthalmic solution; no injectable concentrations listed.

Contradictions

Low

AI Statement
Injectable atropine is commonly available as atropine sulfate in solutions for injection.

Label Reference
Unlabeled in this ophthalmic label

Important Omissions

No mention of injectable dosing or non-ophthalmic indications in label.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The label is for ophthalmic use with limited systemic exposure; many non-label claims describe systemic effects that are not clinically validated by the label.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Not Aligned

Primary Issue
Substantial non-label dosing and non-ophthalmic indications claimed.

Suggested Improvement
Limit claims to ophthalmic atropine sulfate 1% dosing (one drop per eye per day in children 3 months–3 years; up to twice daily as per label), and specify the concentration as 1% (10 mg/mL) for the ophthalmic solution. Remove conditioning statements about injectable dosing and organophosphate pesticides; align with exact label language.

Drug Brand Mention Assessment

Branding Score
84
Visibility
87
Mentioned
Ranking
#1
Sentiment
70
Recommendation Status
strong alternative
Brand Perception
Best Known For

first-line medication for treating hemodynamically unstable bradycardia in adults.

Core Claims
  • The standard adult dose of injectable atropine sulfate for various medical indications is typically 0.4 mg to 0.6 mg, administered subcutaneously, intramuscularly, or intravenously [1].
  • Pediatric atropine sulfate dosage is calculated based on the child's weight.
  • Atropine is a first-line medication for treating hemodynamically unstable bradycardia in adults [2].
  • It is also an antidote for organophosphate and carbamate pesticide poisoning, as well as for certain types of nerve agent exposure [3].
  • Injectable atropine is commonly available as atropine sulfate in solutions for injection. These solutions typically come in concentrations such as 0.4 mg/mL or 1 mg/mL [4].
Differentiators
  • For symptomatic bradycardia, the recommended dose is 0.02 mg/kg, with a minimum dose of 0.1 mg and a maximum dose of 1 mg per administration [2].
  • Atropine is a first-line medication for treating hemodynamically unstable bradycardia in adults [2].
  • It is also considered a critical antidote for organophosphate poisoning [3].
  • Injectable atropine is commonly available as atropine sulfate in solutions for injection. These solutions typically come in concentrations such as 0.4 mg/mL or 1 mg/mL [4].
  • The effects of intravenous atropine typically begin within minutes and can last for about 1 to 4 hours, depending on the dose administered [1].
Pricing Perception: Not Mentioned